JP2015034162A5 - - Google Patents

Download PDF

Info

Publication number
JP2015034162A5
JP2015034162A5 JP2014152352A JP2014152352A JP2015034162A5 JP 2015034162 A5 JP2015034162 A5 JP 2015034162A5 JP 2014152352 A JP2014152352 A JP 2014152352A JP 2014152352 A JP2014152352 A JP 2014152352A JP 2015034162 A5 JP2015034162 A5 JP 2015034162A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
external
fatty acid
polyoxyethylene
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014152352A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015034162A (ja
JP6462260B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014152352A priority Critical patent/JP6462260B2/ja
Priority claimed from JP2014152352A external-priority patent/JP6462260B2/ja
Publication of JP2015034162A publication Critical patent/JP2015034162A/ja
Publication of JP2015034162A5 publication Critical patent/JP2015034162A5/ja
Application granted granted Critical
Publication of JP6462260B2 publication Critical patent/JP6462260B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014152352A 2013-07-11 2014-07-09 泡状外用医薬組成物 Expired - Fee Related JP6462260B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014152352A JP6462260B2 (ja) 2013-07-11 2014-07-09 泡状外用医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013157133 2013-07-11
JP2013157133 2013-07-11
JP2014152352A JP6462260B2 (ja) 2013-07-11 2014-07-09 泡状外用医薬組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018244305A Division JP6755933B2 (ja) 2013-07-11 2018-12-27 泡状外用医薬組成物

Publications (3)

Publication Number Publication Date
JP2015034162A JP2015034162A (ja) 2015-02-19
JP2015034162A5 true JP2015034162A5 (enExample) 2017-08-03
JP6462260B2 JP6462260B2 (ja) 2019-01-30

Family

ID=52542949

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014152352A Expired - Fee Related JP6462260B2 (ja) 2013-07-11 2014-07-09 泡状外用医薬組成物
JP2018244305A Active JP6755933B2 (ja) 2013-07-11 2018-12-27 泡状外用医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018244305A Active JP6755933B2 (ja) 2013-07-11 2018-12-27 泡状外用医薬組成物

Country Status (1)

Country Link
JP (2) JP6462260B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6696767B2 (ja) * 2014-12-24 2020-05-20 株式会社ポーラファルマ スクリーンフォーマー用の外用組成物
JP7269761B2 (ja) 2019-03-15 2023-05-09 三菱重工業株式会社 原料流体の処理プラント、及び原料流体の処理方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504265D0 (en) * 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
GB2443162B (en) * 2006-10-28 2011-02-09 Nupharm Lab Ltd Betamethasone spray
JP5430601B2 (ja) * 2011-04-01 2014-03-05 マルホ株式会社 非エアゾール式フォーム剤用組成物

Similar Documents

Publication Publication Date Title
WO2015195512A3 (en) Method of treating hair with a concentrated conditioner
CL2019001447A1 (es) Preparación de complejos sólidos de ciclodextrina para suministro de ingredientes farmacéuticos activos oftálmicos.
EP3548000A4 (en) PHARMACEUTICAL COMPOSITIONS OF ATROPINE
EA201692334A1 (ru) Кортикостероидные композиции для местного применения
MX2016013693A (es) Crema transdermica.
MX2017008425A (es) Composiciones fungicidas.
MX363626B (es) Metodo para el tratamiento del cabello con un acondicionador concentrado.
MX2016016215A (es) Metodo para el tratamiento del cabello con un acondicionador concentrado.
CL2015000966A1 (es) Combinaciones de compuestos activos que comprenden derivados de carboxamida y un agente de control biológico; composiciones que las comprenden; método de control de hongos fitopatógenos en cultivos que las utiliza; y uso de las combinaciones y composiciones.
EP3151923A4 (en) Clear compositions and methods for the delivery of active ingredients for skin care
JP2015221783A5 (enExample)
MX377302B (es) Composiciones para el cuidado personal con dos fases benéficas.
EP2978420A4 (en) STABLE NANO COMPOSITION WITH DOXORUBICIN, PROCESS FOR THE PREPARATION THEREOF, THE USE THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREWITH
EP3390626A4 (en) LIQUID FORMULATION OF ALPHA AMYLASE
DK3710036T3 (da) Stable ascorbic acid compositions and methods of using the same
FR3024037B1 (fr) Ingredient actif cosmetique ou dermatologique comprenant un melange d'acides dicarboxyliques gras insatures, compositions le comprenant et utilisations cosmetiques ou dermatologiques
WO2016012420A3 (de) Deodorantzubereitungen umfassend polyquaternium-6-polymere
GT201700138A (es) Pirazolpiridinaminas
CO2017003290A2 (es) Composiciones y kits para desbridación enzimática y metodos de uso de los mismos
MX370990B (es) Ésteres de ácidos oligo-hidroxicarboxílicos y uso de los mismos.
EP3347022A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING DUTASTERIDE AND FORMULATION IN CAPSULE COMPRISING SAME
MY181719A (en) Fragrance and flavor compositions comprising neopentyl glycol diacetate
JP2015034162A5 (enExample)
IN2013DE03735A (enExample)
EP2978421A4 (en) STABLE NANO COMPOSITION WITH DOCETAXEL, PROCESS FOR THE PRODUCTION THEREOF, THE USE THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREWITH